Following its acquisition of Kemwell Biopharma’s pharmaceutical contract development and manufacturing (CDMO) businesses– based in Research Triangle Park – earlier this year, Sweden’s Recipharm is making a push in business development efforts stateside.
The company has appointed Aaron Small to oversee growth of its U.S.-based pharmaceutical development services business. He joined the company in 2012.
"The North American market is of great importance for Recipharm and we believe that we…
Following its acquisition of Kemwell Biopharma’s pharmaceutical contract development and manufacturing (CDMO) businesses– based in Research Triangle Park – earlier this year, Sweden’s Recipharm is making a push in business development efforts stateside.
The company has appointed Aaron Small to oversee growth of its U.S.-based pharmaceutical development services business. He joined the company in 2012.
"The North American market is of great importance for Recipharm and we believe that we…